Submit Deal

SANTHERA PHARMACEUTICALS

HQ - Pratteln

Summary

Santhera is a specialty pharmaceutical company based in Switzerland, focused on the development and commercialization of innovative medicines for patients living with rare diseases, particularly neuromuscular and mitochondrial conditions.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 79 M

Avg. Deal Size£ 79 M

Market Context

Senior Management

Dario Eklund
CEO

Sort

20 Jun 2023|Switzerland|Pharmaceuticals

Target: SANTHERA PHARMACEUTICALS

Bidder: CATALYST PHARMACEUTICALS

9 Service Providers

3 Target | 6 Bidder

10 Dealmakers

3 Target | 7 Bidder

£ 78 M

Value

12 Jan 2026|Switzerland|Pharmaceuticals

Target: SANTHERA PHARMACEUTICALS

Bidder: NXERA PHARMA CO LTD

3 Service Providers

1 Target | 2 Bidder

9 Dealmakers

1 Target | 8 Bidder

n/a

Value